Related Experiment Video
Updated: Dec 21, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study
Chingching Foocharoen1, Udomlack Peansukwech2, Ajanee Mahakkanukrauh1
1Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Insights
Diffuse cutaneous systemic sclerosis (dcSSc) is common in Thai patients. Early pulmonary fibrosis detection and factors like older age, high functional class, and organ involvement increase mortality risk in systemic sclerosis (SSc).
Area of Science:
- Rheumatology
- Dermatology
- Pulmonology
Background:
- Systemic sclerosis (SSc) predominantly presents as diffuse cutaneous SSc (dcSSc) in Thai patients, differing from Caucasian and some Asian populations.
- A longitudinal study of Thai dcSSc patients is crucial for understanding disease progression and outcomes.
Purpose of the Study:
- To characterize the clinical features of Thai SSc patients.
- To differentiate between limited cutaneous SSc (lcSSc) and dcSSc.
- To determine SSc mortality rates and associated risk factors.
Main Methods:
- A cohort study of 566 adult Thai SSc patients was conducted from January 2013 to June 2019.
- Generalized estimating equations (GEE) were used to analyze clinical differences between lcSSc and dcSSc.
Main Results:
- The majority of patients were female (72.6%) and had dcSSc (72.6%).
- Pulmonary fibrosis (PF) was detected early (median 2.5 years), with pulmonary arterial hypertension and renal crisis occurring later.
- dcSSc correlated with specific skin manifestations (salt-and-pepper, deformity) and higher modified Rodnan skin scores (mRSS).
- Mortality risk factors included older age at onset, high World Health Organization functional class (FC III/IV), edematous skin, early PF, higher mRSS, and multiple organ involvement.
Conclusions:
- Diffuse cutaneous systemic sclerosis (dcSSc) is the predominant subtype in Thailand.
- Pulmonary fibrosis (PF) is an early complication of SSc, and its early detection indicates a poorer prognosis.
- Factors such as advanced age at onset, severe functional limitation, extensive skin involvement, and multi-organ disease significantly increase mortality risk in SSc patients.
Background:
Most Thai patients with systemic sclerosis (SSc) have diffuse cutaneous SSc (dcSSc) unlike most Caucasians and some Asians. A longitudinal cohort study among Thai dcSSc is needed.
Objectives:
We aimed to determine the overall clinical characteristics, define the clinical difference between limited cutaneous SSc (lcSSc) and dcSSc, and ascertain the mortality rate and the factors associated with mortality.
Method:
We conducted a cohort study including 566 Thai adult SSc patients between January 2013 and June 2019. Clinical difference between lcSSc and dcSSc was investigated using generalized estimating equations (GEE).
Results:
Females presented more than males (356 vs 210 cases). The majority of cases were dcSSc (411; 72.6%). The median duration of disease at the time of pulmonary fibrosis (PF) detection was 2.5 years, pulmonary arterial hypertension 8.1 years, and renal crisis 4.1 years. By GEE analysis, dcSSc was significantly associated with salt-and-pepper skin, hand deformity, and every 1-point increase in modified Rodnan skin score (mRSS). A greater mortality risk was associated with age at onset >60 years (hazards ratio [HR] 5.5), a World Health Organization functional class (FC) III (HR 5.1), FC IV (HR 34.8), edematous skin (HR 11.4), early onset of PF (HR 1.7), each 5-point increase in the mRSS (HR 4.5), and ≥2 internal organ involvements (HR 10.1).
Conclusion:
dcSSc is a common SSc subset among Thais. PF was an early complication in SSc and earlier PF detection was associated with a poorer prognosis. Elderly onset, high FC, severe skin tightness, and multiple organ involvements were associated with a greater mortality risk.
More Related Videos
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome I : Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Nephrotic Syndrome II : Assessment and Medical Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies